Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Kuan‐Li Wu"'
Autor:
Chia‐Yu Kuo, Ming‐Ju Tsai, Jen‐Yu Hung, Mei‐Hsuan Lee, Kuan‐Li Wu, Yu‐Chen Tsai, Cheng‐Hao Chuang, Chung‐Wen Huang, Chin‐Ling Chen, Chih‐Jen Yang, Inn‐Wen Chong
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 5, Pp 467-476 (2024)
Abstract Combining epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an anti‐ vascular endothelial growth factor (VEGF) agent, bevacizumab or ramucirumab, is indicated for advanced lung adenocarcinoma harboring EGFR mutat
Externí odkaz:
https://doaj.org/article/ccc67b4d159f480788789dc5c0166cb1
Publikováno v:
Respirology Case Reports, Vol 12, Iss 9, Pp n/a-n/a (2024)
Key message Tracheal squamous cell carcinoma is a rare and potentially fatal thoracic cancer mimicking common airway disorders. Accurate diagnosis requires a detailed history, thorough physical examination, and high clinical suspicion.
Externí odkaz:
https://doaj.org/article/ed751fa979ee4487b669e27e9a43fdb1
Autor:
Wei-Te Lee, Chih-Lin Huang, Rong-Jyh Lin, Chao-Ju Chen, Kuan-Li Wu, June-Der Lee, Yue-Chiu Su
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 3, Pp 520-522 (2024)
Externí odkaz:
https://doaj.org/article/6972f311a3dc4a1b8eb3c6dc9aca156a
Autor:
Kuan‐Li Wu, Ying‐Ming Tsai, Yung‐Chi Huang, Yu‐Yuan Wu, Chao‐Yuan Chang, Yu‐Wei Liu, Ya‐Ling Hsu, Jen‐Yu Hung
Publikováno v:
Thoracic Cancer, Vol 14, Iss 4, Pp 407-418 (2023)
Abstract Background The poor outcome of patients with lung squamous cell carcinoma (LUSC) highlights the importance of the identification of novel effective prognostic markers and therapeutic targets. Long noncoding RNAs (lncRNAs) have generally been
Externí odkaz:
https://doaj.org/article/18875912212f494fae10aa857169b0d9
Autor:
En‐Chi Hsu, Kuan‐Li Wu, Ying‐Ming Tsai, Mei‐Hsuan Lee, Ming‐Ju Tsai, Chia‐Yu Kuo, Yu‐Chuan Liu, Fu‐Wen Liang, Chih‐Jen Yang, Jen‐Yu Hung
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 10, Pp 1001-1011 (2022)
Abstract Lung squamous cell carcinoma (LUSC) represents a minor proportion of nonsmall cell lung cancer (NSCLC) harboring a poor prognosis. Herein, retrospective medical record research was performed to investigate real‐world treatment patterns and
Externí odkaz:
https://doaj.org/article/db029e59fd1b48689719a60fac4223f8
Autor:
Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai, Ya-Ling Hsu
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 431 (2022)
Lung cancer is one of the deadliest cancers worldwide, including in Taiwan. The poor prognosis of the advanced lung cancer lies in delayed diagnosis and non-druggable targets. It is worth paying more attention to these ongoing issues. Public database
Externí odkaz:
https://doaj.org/article/c5985482919f462b9fa7cdafcbb55a7e
Autor:
Ying-Ming Tsai, Kuan-Li Wu, Yu-Wei Liu, Wei-An Chang, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Szi-Hui Liao, Jen-Yu Hung, Ya-Ling Hsu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundAngiogenesis is required for tumor development and metastasis, which is a major part in a pro-tumor microenvironment. Vascular mimicry (VM) is a process in which cancer cells, rather than endothelia, create an alternative perfusion system t
Externí odkaz:
https://doaj.org/article/e45b0769f76f499bb1cddfbe4e0d2763
Publikováno v:
Respirology Case Reports, Vol 9, Iss 6, Pp n/a-n/a (2021)
Abstract Dasatinib is a potent and effective second‐generation oral tyrosine kinase inhibitor that is clinically indicated for the treatment of imatinib‐resistant or imatinib‐intolerant breakpoint cluster region‐Abelson (BCR‐ABL)‐positive
Externí odkaz:
https://doaj.org/article/2e7892ed9ada4788a2dfff380d79bd9c
Autor:
Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, Po-Lan Su, Chun-Liang Lai, Huang-Chih Chang, Te-Chun Hsia, Sheng-Hao Lin, Kuan-Li Wu, Cheng-Ta Yang, Wu-Chou Su, Yi-Chun Chu, Chin-Chou Wang, Wei-Yu Liao, Yen-Ting Lin, Ching-Hsiung Lin, Meng-Chih Lin, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Mei-Hsuan Lee, Sung-Liang Yu, Chao-Chi Ho, Gee-Chen Chang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The relative importance of predictive factors for advanced non-small cell lung cancer (NSCLC) patients on epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment remains unclear. Materials and methods: We retrosp
Externí odkaz:
https://doaj.org/article/7f3ee24a699d4939b0d05e532d1f3581
Autor:
Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Ying-Ming Tsai, Jen-Yu Hung
Publikováno v:
Biology, Vol 11, Iss 7, p 975 (2022)
Lung adenocarcinoma (LUAD) is a common type of lung cancer. Although the diagnosis and treatment of LUAD have significantly improved in recent decades, the survival for advanced LUAD is still poor. It is necessary to identify more targets for develop
Externí odkaz:
https://doaj.org/article/6a85db564cdf455eab6f3cec9d9cea98